It’s reasonable, and perhaps preferable, to switch frail older patients with atrial fibrillation (AF) from a vitamin K antagonist like warfarin to a direct oral anticoagulant (DOAC) for stroke ... Are frail older adults with atrial fibrillation (AF) better off sticking with warfarin, the tried-and-true vitamin K antagonist? Maybe not, according to new data in the Journal of the American College ...
Patients with thrombotic antiphospholipid syndrome are better treated with a vitamin K antagonist, such as warfarin, rather than a direct oral anticoagulant (DOAC), a new systematic review and ... Healio: Diabetes complications less likely in non-vitamin K antagonist oral anticoagulant users Please provide your email address to receive an email when new articles are posted on . Adults with atrial fibrillation and diabetes who received non-vitamin K antagonist oral anticoagulants had a ... Medscape: Is Warfarin Still an Option for Frail Patients With Atrial Fibrillation?
antagonist of warfarin, Monthly Prescribing Reference: Balfaxar Approved for Warfarin Reversal in Urgent Surgery, Invasive Procedures Nasdaq: Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress
